InvestorsHub Logo
Followers 85
Posts 314
Boards Moderated 0
Alias Born 06/20/2020

Re: jokinjoe post# 52982

Friday, 12/04/2020 12:07:20 AM

Friday, December 04, 2020 12:07:20 AM

Post# of 198385
oh wow this is money, thanks. Check this out:

"A Novel Peptide Immunotherapy to Treat Severe, Late Stage SARS-COV-2 Infection

Principal Investigator: M. Karen Newell-Rogers, Ph.D., College of Medicine, Texas A&M University

Project Summary: This DOD application proposes to study an immunotherapy, Competitive Antagonist Peptide (CAP), to treat life-threatening symptoms associated with severe COVID19. The rationale for use of CAP to fight COVID-19-syndromes is based on CAP’s dual capabilities to: (1) treat and resolve hyper-inflammation by reducing inflammatory cytokines (IL-1beta, IL-6, TNFalpha); and (2) expand CD8+ T cells. CAP's anti-inflammatory properties have been demonstrated in 4 pre-clinical models of inflammatory disease."

Could this be $ENZC going for the Late Stage problem that Lilly and REGN both tapped out on? Both LLY AND REGN stopped their clinical trials for late stage.

https://vpr.tamu.edu/research-index-for-covid-19

WHOA!!!!